Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Arcis Biotechnology Ltd.. (1/30/17). "Press Release: Arcis Biotechnology Awarded Funding under Innovate UK’s Biocatalyst Programme". Daresbury.

Region Region United Kingdom (GB)
Organisations Organisation Arcis Biotechnology Ltd.
  Group Arcis:Altos (Group)
  Organisation 2 Innovate UK
  Group United Kingdom (GB) (govt)
Products Product nucleic acid extraction (technology)
  Product 2 business development (state/region)
Index term Index term Arcis:Altos–United Kingdom (govt): grant, 201701– Innovate UK Biocatalyst funding £160k for Arcis Bio for RNA extraction + stabilisation from urine

Funding will be used for feasibility study to investigate use of RNA extracted from urine for clinical diagnostic assays

Daresbury, UK, 30 January 2017: Arcis Biotechnology, the nucleic acid sample preparation solution provider, today announced it has been awarded £160,000 funding under Innovate UK’s Biocatalyst programme, to be awarded over a 12 month period. The funding will be used to assess the technical feasibility of extracting and stabilising RNA direct from urine, for use in biomarker-based clinical diagnostic assays.

RNA is inherently susceptible to degradation, making sample collection and storage near impossible, whether collecting from a remote location or for home testing. Arcis Biotechnology has developed a procedure to simplify RNA extraction and stabilise the RNA pool for up to 26 days. This project seeks to explore the feasibility of adapting this process to extract and stabilise RNA direct from urine. The process could then be applied to develop a kit for home sample collection and transfer to a clinical laboratory, to test for prostate and bladder cancers, amongst other conditions.

RNA sequences expressing altered proteins are potentially useful as diagnostic markers, and may be quantified using quantitative reverse transcriptase polymerase chain reaction (qrtPCR). However, primarily due to the difficulties associated with storage and degradation, the use of RNA quantification for disease diagnosis for some cancers, particularly prostate cancer, has previously been limited due to the necessity for the patient to be in close proximity to the equipment.

Dr Jan Rogers, CSO, Arcis Biotechnology, commented: “The ability to validate and use RNA biomarkers for clinical diagnostics is potentially game-changing, and being able to extract and store RNA from urine samples would offer clinicians a simple, minimally invasive diagnostic procedure. We are delighted that Innovate UK has identified the potential opportunity provided by our RNA extraction and stabilisation technology.”


Notes to editors

Media contact:

Katie Odgaard
Zyme Communications
Tel: +44(0) 7787 502 947

About Arcis Biotechnology (

Arcis Biotechnology is focused on providing fast and convenient nucleic acid sample prep solutions. Obtaining genetic material from biological samples is a critical step which is often a time consuming and inefficient process. In less than 3 minutes with no prior sample preparation the Arcis DNA Prep range of products allow users to quickly and conveniently go from cellular material to downstream nucleic acid investigation without the need for traditional isolation or purification. The process requires no laboratory equipment and requires as little as 30µl of blood as a starting material. Arcis DNA products can be used on many different samples containing DNA including whole blood, plasma, urine, buccal swabs, and hair follicles and microbiological samples including bacteria (E. coli, S. aureus, P. aeruginosa, K. pneumoniae), viruses (HBV/ HCV) and parasites (plasmodium).

About Innovate UK

Innovate UK is the UK’s innovation agency. It works with people, companies and partner organisations to find and drive the science and technology innovations that will grow the UK economy.

For further information visit

Record changed: 2018-10-18


Picture [iito] Made Without Love 650x80px

More documents for Arcis:Altos (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top